Brain perfusion after treatment of childhood acute lymphoblastic leukemia

Journal of Nuclear Medicine

Volumn 38, Issue 1, 1997, Pages 82-88

  Harila Saari, Arja H ^a,b   Ahonen, Aapo K A ^a   Vainionpää, Leena K ^a   Pääkkö, Eija L ^a   Pyhtinen, Juhani ^a   Himanen, A Sinikka ^a   Torniainen, Pentti J ^a   Lanning, B Marjatta ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

acute lymphoblastic leukemia; brain perfusion; methotrexate neurotoxicity; SPECT

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APTITUDE TEST; ARTICLE; BRAIN PERFUSION; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; CYSTEINE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; NEUROLOGIC EXAMINATION; ORGANOTECHNETIUM COMPOUNDS; OXIMES; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031031392     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Meadows AT, Gordon J, Massari DJ, Littman P, Fergusson J, Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukemia treated with cranial irradiation. Lancet 1981;2:1015-1018.
2. Pääkkö E, Vainionpää L, Pyhtinen J, Lanning M. Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukemia. Neuroradiology 1996;38:264-268.
3. Phillips PC, Moeller JR, Sidtis JJ, et al. Abnormal cerebral glucose metabolism in long-term survivors of childhood acute lymphocystic leukemia. Ann Neurol 1991;29: 263-271.
4. Komatsu K, Takada G, Uemura K, Shishido F, Kanno I. Decrease in cerebral metabolic rate of glucose after high dose methotrexate in childhood acute lymphocystic leukemia. Pediatr Neurol 1990;6:303-306.
5. Vainionpää L. Clinical neurological findings in children with acute lymphoblastic leukemia at diagnosis and during treatment. Eur J Pediatr 1993;152:115-119.
6. 24Gy or no cranial irradiation. J Clin Oncol 1991;9:1348-1356.
7. Jaffe N, Takaue Y, Anzai T, Robertson R. Transient neurotic disturbances induced by high-dose methotrexate treatment. Cancer 1985;56:1356-1360.
8. Suzuki K, Takemura T, Okeida R, Hatakeyama S. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy. Acta Neuropathol 1984;65: 145-149.
9. Mizusawa S, Kondoh Y, Murakami M, et al. Effect of methotrexate on local cerebral blood flow in conscious rats. Jpn J Pharmacol 1988;48:499-501.
10. Gustafsson G, Garwics S, Herz H, et al. A population based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Acta Paediatr Scand 1987;76:781-788.
11. Riehm H, Reiter A, Scrappe M, et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphohlastic leukemia in childhood (therapy study ALL-BFM 83) (in German). Klin Pädiatr 1987;199:151-160.
12. 2). N Engl J Med 1983;308:559-565.
13. Podreka I, Suess E, Goldenberg T, et al. Initial experience with technetium-99m-HMPAO brain SPECT. J Nucl Med 1987;26:1657-1666.
14. Korkman M. NEPSY. A proposed neuropsychological test battery for young developmentally disabled children. PhD dissertation, Yliopistopaino, Helsinki; 1988.
15. Wechsler D. Manual for the Wechsler preschool and primary scale of intelligence. San Antonio, TX: Psychological Corp.: 1967.
16. Wechsler D. Manual for the Wechsler intelligence scale for children. San Antonio, TX: The Psychological Corp.; 1949.
17. Wechsler D. Manual for the Wechsler adult intelligence scale. New York: Psychological Corp.; 1955.
18. Touwen BLC. Examination of the child with minor neurological dysfunction, 2nd ed. Clinics in developmental medicine No. 71. London: Heinemann Medical; 1979.
19. Balis FM, Poplack DG. Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol 1989;11:74-85.
20. Bleyer WA. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 1981;65(suppl 1):89-98.
21. Fleisher M. Antifolate analogs: Mechanism of action, analytical methodology and clinical efficacy. Ther Drug Monit 1993;15:521-526.
22. 2 intravenous methotrexate. Pediatric Res 1995;37:151-154.
23. Lou HC, Edvinsson L, MacKenzie ET. The concept of coupling blood flow to brain function: revision required? Ann Neurol 1987;22:289-297.
24. Land VJ, Shuster JJ, Crist WM, et al. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol 1994;12:1939-1945.
25. Baker WJ, Royer GL, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol 1991;9:679-693.
26. Ochs JJ, Parvey LS, Whitaker JN, et al. Serial cranial computed tomography scans in children with leukemia given two different forms of central nervous system therapy. J Clin Oncol 1983;1:793-798.
27. Yeung WT, Lee TY, DelMaestro RF, Kozak R, Bennet J, Brown T. Effect of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with x-ray computed tomography. J Neuro Oncol 1993;18:53-60.
28. Barks JD, Post M, Tuor UI. Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatric Res 1991;29:558-563.
29. Balis FM, Lester CM, Chrousos GP, et al. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987;5:202-207.
30. Lenn NJ. Brain plasticity and regeneration. Am J Neuroradiol 1992;13:505-515.
31. Casey EB. Vincristine neuropathy: clinical and electrophysiological observations. Brain 1973;96:69-86.
32. Fisher M, Sotak CH, Minematsu K, Li L. New magnetic resonance techniques for evaluating cerebrovascular disease. Ann Neurol 1992;32:115-122.